Fatty dorsal hump
Specialty: Endocrine and metabolic.
Why it occurs
- Cushing syndrome of any etiology (cortisol stimulates central lipogenesis in specific body areas such as the neck, face and trunk, while promoting lipolysis in extremities)
- Lipodystrophy associated with antiretroviral therapy in patients with HIV (adverse effect of protease inhibitors and nucleoside reverse transcriptase inhibitors that alter the mitochondrial function of adipocytes)
- Obesity of android or central distribution (simple adipose accumulation without demonstrable underlying neuroendocrine dysregulation)
- Madelung syndrome or multiple symmetric lipomatosis (rare metabolic disorder that causes massive deposits of non-encapsulated fat in the neck, shoulders and upper trunk)
Initial workup
Hypercortisolism screening protocol using free cortisol in 24-hour urine and suppression test with low-dose dexamethasone; complete lipid profile and fasting glucose determination; complete blood count and serum electrolytes; bone densitometry of the lumbar spine and femoral neck; and CT of the abdomen if tumor pathology of the adrenal gland is suspected.
red flags
Presence of a fatty hump accompanied by extreme thinning of the skin with a propensity for ecchymosis with minimal trauma, severe proximal muscle weakness (inability to get up from a chair without support), accelerated osteoporosis with spontaneous vertebral fractures, or signs of rapid androgen virilization in women.
Standard management
- Osilodrostat — potent inhibitor of 11-beta-hydroxylase, a terminal enzyme of the cortisol synthesis pathway, used in Cushing's disease refractory to surgery
- Pasireotide — second generation somatostatin analogue with high affinity for the sst5 receptor, indicated to reduce ACTH secretion
- Mitotano — selective adrenolytic and cytotoxic agent of the adrenal cortex, used in the management of advanced adrenal carcinoma
- Rosiglitazone — insulin sensitizer that can modulate fat redistribution in specific forms of insulin resistance, with close cardiovascular monitoring
Educational guidance for study. It is NOT a prescription recommendation. The actual choice depends on the cause, the patient, and current guidelines.
- Area
- Endocrine and metabolic
- Listed causes
- 4
- Treatment options
- 4